Show Results For
- All HBS Web (382)
- Faculty Publications (112)
Show Results For
- All HBS Web (382)
- Faculty Publications (112)
- January 1993 (Revised October 1993)
- Case
Medtronic, Inc.
- March 1999
- Case
Merck & Co., Inc.: Corporate Strategy, Organization and Culture (A)
- July 2018 (Revised August 2018)
- Case
Project Helios: Harvesting the Sun
- September 2016 (Revised September 2016)
- Case
The Tavistock Group and the Australian Agricultural Company
Eugene F. Soltes
Eugene Soltes is a Professor of Business Administration at Harvard Business School where his work focuses on corporate integrity and risk management. His research utilizes data analytics to identify organizational cultures and compliance systems that can effectively... View Details
- October 2012 (Revised September 2014)
- Case
Doing Business in Vietnam
- 14 Dec 2016
- Working Paper Summaries
The State of Small Business Lending: Innovation and Technology and the Implications for Regulation
- January 2025
- Case
COMAC - Chinese Aviation Soars to New Heights
- 04 Sep 2007
- Research & Ideas
Jumpstarting Innovation: Using Disruption to Your Advantage
- Research Summary
Other research activities
Apart from my dissertation research on the EU ETS, I am interested in topics such as foreign direct investment, global strategy, institutions and sustainability. I am currently working with several faculty members at Harvard Business School on issues ranging from... View Details
- 20 Nov 2007
- First Look
First Look: November 20, 2007
Ana Antolin
Ana Antolin is a doctoral candidate in the Strategy unit at Harvard Business School. She received her B.S. in Quantitative Economics and International Relations from Tufts University. Prior to joining Harvard, she worked as a full-time research assistant in... View Details
- February 1992 (Revised September 2019)
- Case
The House of Tata
- August 2002 (Revised December 2002)
- Case
AOL Europe vs. Freeserve (A)
- 05 May 2003
- Research & Ideas
Greed, Fear, and The System Hinder Corporate Reform
- Article
Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
- 2000
- Chapter
Anticipating Greener Supply Chain Demands: One Singapore Company's Journey to ISO 14001
- September 2019
- Case
Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem
- 04 Feb 2019
- News
The PCAOB as Third-party Payer
- February 2024
- Module Note